Furthermore, mice with proteoglycan and CFA-induced arthritis were treated with guanethidine (to deplete postganglionic sympathetic terminals) or capsaicin (to destroy TRPV1+ sensory terminals) had reduced pain behavior, edema, and arthritis severity (51, 54). This evidence concerns the gene TRPV1 and arthritic joint disease.